EUS Guided Portal-systemic Pressure Gradient Measurement to Predict Treatment Response and Outcomes of Varices to Endoscopic Variceal Ligation in Patients With Chronic Hepatitis.
The aim of the current study is to assess if EUS-PPGM could predict the treatment response and outcomes of varices to endoscopic variceal ligation (EVL) in patients with chronic hepatitis. The hypothesis is that a high EUS-PPGM value at 3 months correlates with the presence of varices requiring EVL in patients that have received primary or secondary variceal prophylaxis on 1 year follow-up upper endoscopy.
• Age between 18 to 75 years old
• Informed consent available
• Suffering from chronic hepatitis induced cirrhosis
• Suffering from oesophageal varices and received EVL as a result of
‣ Primary variceal prophylaxis during a variceal surveillance program on oesophagogastroduodenoscopy (OGD) or
⁃ Secondary variceal prophylaxis after EVL in patients with active oesophageal variceal bleeding
• Or bleeding gastric varices that have received endoscopic canoacrylate injection